GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EVGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Evogene Ltd
(Updated on Apr 19, 2024)

Sell candidate since Apr 12, 2024 Loss -17.62% PDF

The Evogene Ltd stock price fell by -4.49% on the last day (Friday, 19th Apr 2024) from $0.641 to $0.612. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.81% from a day low at $0.612 to a day high of $0.660. The price has fallen in 7 of the last 10 days and is down by -17.48% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -31 thousand shares and in total, 72 thousand shares were bought and sold for approximately $44.12 thousand.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($0.635) are considered to be a "second chance" to get out. According to the fan-theory $0.328 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EVGN Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Evogene Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.687 and $0.792. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -37.55%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Evogene Ltd stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0478 between high and low, or 7.81%. For the last week the stock has had daily average volatility of 6.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EVGN) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Evogene Ltd to open at $0.628, and during the day (based on 14 day Average True Range), to move between $0.560 and $0.664, which gives a possible trading interval of +/-$0.0516 (+/-8.42%) up or down from last closing price. If Evogene Ltd takes out the full calculated possible swing range there will be an estimated 16.85% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.730, some $0.118 (19.28%) from the current price of $0.612, our system finds the risk reward not very attractive.

Is Evogene Ltd stock A Buy?

Evogene Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -8.237 Strong Sell Candidate Unchanged

Predicted Opening Price for Evogene Ltd of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$0.628 ( 2.60%) $0.612

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EVGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.676 10.41 %
R2 0.657 7.43 %
R1 0.646 5.59 %
Current price: 0.612
Support S1 0.610 -0.380 %
S2 0.598 -2.22 %
S3 0.580 -5.21 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.760 24.18 %
R2 0.746 21.90 %
R1 0.730 19.28 %
Current price 0.612
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Evogene Ltd Stock and on which exchange is it traded?
The symbol for Evogene Ltd is EVGN and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Evogene Ltd Stock?
Evogene Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Evogene Ltd Stock?
Evogene Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Evogene Ltd Stock.

What's the current price of Evogene Ltd Stock?
As of the end of day on the 2024-04-19, the price of an Evogene Ltd (EVGN) share was $0.612.

What is the 52-week high and low for Evogene Ltd Stock?
The 52-week high for Evogene Ltd Stock is $1.44 and the 52-week low is $0.450.

What is the market capitalization of Evogene Ltd Stock?
As of the 2024-04-19, the market capitalization of Evogene Ltd is 34.627M.

When is the next earnings date for Evogene Ltd?
The upcoming earnings date for Evogene Ltd is May 16, 2024.
Click to get the best stock tips daily for free!

About Evogene Ltd

Evogene Ltd Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover... EVGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT